The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Adaptive Biotechnologies Corp’s stock clocked out at $7.28, up 1.53% from its previous closing price of $7.17. In other words, the price has increased by $1.53 from its previous closing price. On the day, 1.82 million shares were traded. ADPT stock price reached its highest trading level at $7.45 during the session, while it also had its lowest trading level at $7.05.
Ratios:
To gain a deeper understanding of ADPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.81 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 1.04.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 13 ’25 when GRIFFIN MICHELLE RENEE bought 36,291 shares for $7.19 per share.
HERSHBERG ROBERT sold 53,000 shares of ADPT for $402,270 on Mar 12 ’25. The Director now owns 69,690 shares after completing the transaction at $7.59 per share. On Mar 10 ’25, another insider, NEUPERT PETER M, who serves as the Director of the company, sold 10,000 shares for $7.05 each. As a result, the insider received 70,500 and left with 224,690 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 1081676928 and an Enterprise Value of 1081826432. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.04 while its Price-to-Book (P/B) ratio in mrq is 5.31. Its current Enterprise Value per Revenue stands at 6.045 whereas that against EBITDA is -7.949.
Stock Price History:
The Beta on a monthly basis for ADPT is 1.73, which has changed by 1.2893081 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, ADPT has reached a high of $8.95, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is -4.19%, while the 200-Day Moving Average is calculated to be 34.24%.
Shares Statistics:
It appears that ADPT traded 1.59M shares on average per day over the past three months and 2300300 shares per day over the past ten days. A total of 147.77M shares are outstanding, with a floating share count of 141.69M. Insiders hold about 4.64% of the company’s shares, while institutions hold 92.61% stake in the company. Shares short for ADPT as of 1740700800 were 8663017 with a Short Ratio of 5.45, compared to 1738281600 on 8530375. Therefore, it implies a Short% of Shares Outstanding of 8663017 and a Short% of Float of 7.470000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
